Oxford BioMedica plc - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Oxford BioMedica plc. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Oxford BioMedica plc. The Group's principal activity is researching and developing genebased medicines and therapeutic vaccines based on a broad technology platform. The Group's development pipeline comprises four products in clinical development and a late-stage preclinical candidate. The lead product is TroVax,a therapeutic vaccine that has potential application in a range of tumour types. The product is designed to stimulate a specific anti-cancer immune response against a protein called 5T4. The Group's other products are Hi-8 MEL, MetXia, ProSavin and RetinoStat. The Group operates in the United Kingdom and the United States of America.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report